Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody

OBJECTIVE: To clarify the risk of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) related to anti-cyclic citrullinated peptide (CCP) antibody. ELIGIBILITY CRITERIA: Patients with RA with and without ILD were eligible. The primary outcome was the prevalence or incidence of ILD. Pri...

Descripción completa

Detalles Bibliográficos
Autores principales: Kamiya, Hiroyuki, Panlaqui, Ogee Mer
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016072/
https://www.ncbi.nlm.nih.gov/pubmed/33789847
http://dx.doi.org/10.1136/bmjopen-2020-040465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016072/
https://www.ncbi.nlm.nih.gov/pubmed/33789847
http://dx.doi.org/10.1136/bmjopen-2020-040465

Ejemplares similares